Wei Chen

Dr. Wei Chen


Research Focus & Metrics

Academic Career Length

5Years (2022-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
4 April 2022 in Disease Markers
Verified
Journal Article
Open access
PDF file
SXShaohua Xu
Shaohua Xu
HMHui Miao
Hui Miao
LGLiming Gong
Liming Gong
LFLijie Feng
Lijie Feng
XHXuliang Hou
Xuliang Hou
WCWei Chen
Wei Chen
Objective. To investigate the optimal temperature of hypothermia treatment in rats with cardiac arrest caused by ventricular fibrillation (VF) after the return of spontaneous circulation (ROSC). Methods. A total of forty-eight male Sprague-Dawley rats were induced by VF through the guidewire with a maximum of 5 mA current and untreated for 8 min. Cardiopulmonary resuscitation (CPR) was performed for 8 min followed by defibrillation (DF). Resuscitated rats were then randomized into the normothermia (37°C) group, milder (35°C) group, mild (33°C) group, or moderate (28°C) group. Hypothermia was immediately induced with surface cooling. The target temperature was maintained for 4 h before rewarming to . Moreover, at the end of the 4 h, a rat in each group was randomly selected to be sacrificed for the cerebral cortex electron microscopy observation ( ). The other resuscitated animals were observed for up to 72 h after ROSC ( ). Left ventricular ejection fraction (LVEF) and left ventricular end diastolic volume (LVEDV) were measured. Survival time, survival rate, and neurological deficit score (NDS) were recorded for 72 h. Results. During hypothermia, higher LVEF was observed in the hypothermia groups when compared with normothermia group (35°C vs. 37°C, , 33°C and 28°C vs. 37°C, ). Among the hypothermia groups, LVEF was higher in the 28°C group than that of 35°C ( ). However, both the heart rate (HR) ( ) and LVEDV (28°C vs. 35°C, , 28°C vs. 37°C and 33°C, ) were lowest in the 28°C group when compared with the other groups. There were no significant differences of LVEF and LVEDV between the group 35°C and 33°C ( ). After rewarming, the LVEF of 35°C group was higher than that of group 37°C, 33°C, and 28°C (35°C vs. 37°C and 28°C, , 35°C vs. 33°C, ). Group 35°C and 33°C resulted in longer survival ( ), higher survival rate ( ), and lower NDS (35°C vs. 37°C and 28°C, , 33°C vs. 37°C and 28°C, ) compared with the group 37°C and 28°C. The extent of damage to cerebral cortex cells in group of 35°C and 33°C was lighter than that in group of 37°C and 28°C. The 35°C group spent less time in the process of cooling and rewarming than the group 33°C and 28°C (

15 January 2023 in Shock
Verified
Journal Article
Closed access
MYMengyang Yu
Mengyang Yu
CZChengying Zhang
Chengying Zhang
SWSitong Wan
Sitong Wan
YLYang Lu
Yang Lu
YWYufei Wang
Yufei Wang
YLYahua Liu
Yahua Liu
Purpose: Cystatin C (CysC) has been linked to the prognosis of corona virus disease 2019 (COVID-19). The study aims to investigate a predictor correlated with CysC screening for poor prognosis in COVID-19 patients combined with skeletal muscle (SKM) impairment and rhabdomyolysis (RM). Methods: A single-center retrospective cohort analysis was carried out. Demographic information, clinical data, laboratory test results, and clinical outcome data were gathered and analyzed. Results: According to the inclusion and exclusion criteria, 382 patients were included in this study. The subjects were divided into three groups based on CysC tertiles. Multivariate analysis revealed that SaO2 (hazard ratio [HR], 0.946; 95% confidence interval [CI], 0.906–0.987; P = 0.011), CysC (HR, 2.124; 95% CI, 1.223–3.689; P = 0.008), aspartate aminotransferase (AST) (HR, 1.009; 95% CI, 1.000–1.018; P = 0.041), and hypersensitive C-reactive protein (HR, 1.005; 95% CI, 1.000–1.010; P = 0.045) were significantly associated with survivals. The area under curve (AUC) in the model characterized by RM incidence was 0.819 (0.698–0.941), as shown by CysC receiver operating characteristic curves. LDH*CysC and AST*CysC had better predictive values than CysC and the best prediction for RM, with an AUC of 0.880 (0.796,0.964) for LDH*CysC (P < 0.05, vs CysC) and 0.925 (0.878,0.972) for AST*CysC (P < 0.05, vs CysC). Conclusion: CysC is an essential evaluation indicator for COVID-19 patients' prognosis. AST*CysC and LDH*CysC have superior predictive value to CysC for SKM, RM, and death, and optimal classification for RM.

3 January 2025 in International Journal of Computers Communications & Control
Verified
Journal Article
Open access
PDF file
YLYinzhen Lv
Yinzhen Lv
JWJiayi Weng
Jiayi Weng
JLJing Li
Jing Li
WCWei Chen
Wei Chen
HHHe Huang
He Huang
YZYuzhuo Zhao
Yuzhuo Zhao
Traumatic pneumothorax is a complex condition that is challenging to diagnose, particularly in hospitals, underdeveloped areas, and during mass casualty events. This study aimed to evaluate the potential of machine learning (ML) for diagnosing and assessing traumatic pneumothorax. We extracted 33 vital signs and blood gas parameters from the MIMIC-IV database, selecting 12 clinically significant features as inputs to four ML algorithms: extreme gradient boosting (XGBoost), artificial neural network (ANN), support vector machine (SVM), and k-nearest neighbors (KNN). Five-fold cross-validation was used to train and test the models, with external validation performed on the EICU database. Model performance was evaluated using AUROC, recall, and accuracy, with SHAP interpretability employed to understand feature importance. In total, 3871 participants from the MIMIC-IV database and 22,022 participants from the EICU database were analyzed. Hemoglobin, Oxygenation Index, and pH were found to be key indicators of severe traumatic pneumothorax. XGBoost exhibited the best performance, achieving an AUROC of 0.979 (95% CI: [0.966, 0.989]) on the MIMIC-IV dataset and 0.806 (95% CI: [0.740, 0.864]) on the EICU dataset. The results suggest that ML, particularly XGBoost, is faster and more convenient than traditional imaging methods, making it well-suited for emergency or mass casualty situations. ML algorithms show promise for initial diagnosis of traumatic pneumothorax, with XGBoost demonstrating strong interpretability and robust external validation.